Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cryoablation Shows Potential as Alternative to Partial Nephrectomy

By HospiMedica International staff writers
Posted on 04 Jan 2017
Researchers from the US have presented the results of a study that suggest that CT or MRI image-guided percutaneous cryoablation could be an effective and safe first-line therapy to treat patients with T1 renal cell carcinoma.

While the current standard treatment for T1 renal cell carcinoma is partial nephrectomy, image-guided cryoablation has been used in the past 15 to 20 years as a very good alternative treatment.

The results of the study were presented at the annual Radiological Society of North America (RSNA 2016) meeting, by researchers from the Brigham & Women's Hospital (BWH; Boston, MA, USA). More...
Image-guided cryoablation is much less invasive than partial nephrectomy and only requires the insertion of one or several needles into the tumor, and the subsequent freezing of the tumor.

The study included 285 patients with solitary renal cell carcinomas who were treated with percutaneous image-guided cryoablation. Tumors were ablated using between one and seven cryoprobes, and image guidance was provided using Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scans.

The results showed a success rate (no tumor recurrence) of 97.8% for the cryoablation treatments. The overall success rate was 99% if patients underwent a second ablation because of disease recurrence. The overall survival rates after five years and 10 years were 90% and 79% respectively. The disease-specific survival rate was 98%, and 10-year cancer-free survival was 94%.

Co-author of the study, Kemal Tuncali, MD, from the BWH, said, "A number of studies have been published looking at image-guided ablation or radio frequency ablation of kidney tumors, but all have been relatively small series. The advantage of our study is that it included a larger patient population and included intermediate and long-term follow ups."

Related Links:
Brigham & Women's Hospital


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Monitor/Defibrillator
Zenix
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.